Sanober Kable, M.D. – FDA Inspection, Aug 21, 2024

Record Details

This FDA Inspection record concerns Sanober Kable, M.D., with an inspection on August 21, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Sanober Kable, M.D.
Inspection Date: August 21, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Joanne M. Schlossin (Issuing Officer)

View Company Profile

ID · 2f837752-2554-4602-aa3f-a160c6d45a5b

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1248324
FDA center: Human Drugs
Project area: Bioresearch Monitoring

FDA Citations

21 CFR 312.62(b)Case history records- inadequate or inadequate

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sanober Kable, M.D.

FDA Inspection

Sanober Kable, M.D.August 21, 2024